Troy A. Ignelzi is Chief Financial Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 30,487 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Aug 22, 2023, when has been sold 1,500 shares (Common Stock) at a price of $175.18 per share, resulting in proceeds of $262,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.5K
0% 3M change
0% 12M change
Total Value Held $0

Troy A. Ignelzi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2023
SELL
Open market or private sale
$262,770 $175.18 p/Share
1,500 Reduced 4.69%
30,487 Common Stock
Aug 22 2023
BUY
Exercise of conversion of derivative security
$13,799 $9.2 p/Share
1,500 Added 4.48%
31,987 Common Stock
May 23 2023
SELL
Open market or private sale
$2,013,030 $223.67 p/Share
9,000 Reduced 22.79%
30,487 Common Stock
May 23 2023
BUY
Exercise of conversion of derivative security
$82,800 $9.2 p/Share
9,000 Added 18.56%
39,487 Common Stock
Feb 21 2023
SELL
Open market or private sale
$1,140,060 $190.01 p/Share
6,000 Reduced 16.44%
30,487 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
$55,199 $9.2 p/Share
6,000 Added 14.12%
36,487 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
8,650 Added 22.1%
30,487 Common Stock
Jan 18 2023
SELL
Open market or private sale
$40,028 $200.14 p/Share
200 Reduced 0.91%
21,837 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$1,839 $9.2 p/Share
200 Added 0.9%
22,037 Common Stock
Jan 17 2023
SELL
Open market or private sale
$164,551 $201.41 p/Share
817 Reduced 3.61%
21,837 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$7,516 $9.2 p/Share
817 Added 3.48%
22,654 Common Stock
Dec 16 2022
BUY
Exercise of conversion of derivative security
$109,176 $9.2 p/Share
11,867 Added 35.21%
21,837 Common Stock
Nov 15 2022
SELL
Open market or private sale
$3,726,525 $225.85 p/Share
16,500 Reduced 62.33%
9,970 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
$151,800 $9.2 p/Share
16,500 Added 38.4%
26,470 Common Stock
Oct 04 2022
SELL
Open market or private sale
$93,280 $233.2 p/Share
400 Reduced 3.86%
9,970 Common Stock
Oct 03 2022
SELL
Open market or private sale
$947,551 $231.11 p/Share
4,100 Reduced 28.33%
10,370 Common Stock
Sep 30 2022
SELL
Open market or private sale
$2,404,605 $229.01 p/Share
10,500 Reduced 42.05%
14,470 Common Stock
Aug 09 2022
SELL
Open market or private sale
$3,759,195 $227.83 p/Share
16,500 Reduced 39.79%
24,970 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$151,800 $9.2 p/Share
16,500 Added 28.46%
41,470 Common Stock
Apr 21 2022
SELL
Open market or private sale
$5,378 $134.46 p/Share
40 Reduced 0.16%
24,970 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$368 $9.2 p/Share
40 Added 0.16%
25,010 Common Stock
Apr 20 2022
SELL
Open market or private sale
$93,773 $133.2 p/Share
704 Reduced 2.74%
24,970 Common Stock
Apr 20 2022
BUY
Exercise of conversion of derivative security
$6,477 $9.2 p/Share
704 Added 2.67%
25,674 Common Stock
Apr 19 2022
SELL
Open market or private sale
$457,835 $130.81 p/Share
3,500 Reduced 12.29%
24,970 Common Stock
Apr 19 2022
BUY
Exercise of conversion of derivative security
$32,200 $9.2 p/Share
3,500 Added 10.95%
28,470 Common Stock

Also insider at

CINC
CinCor Pharma, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
RAPP
Rapport Therapeutics, Inc.
TAI

Troy A. Ignelzi

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX